Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Gregory L. Weaver
Age : 64
Public asset : 76,429 USD
Linked companies : Atai Life Sciences N.V. - Atossa Therapeutics, Inc. - NOXXON Pharma N.V.
Summary 
Currently, Gregory L. Weaver is Chief Financial Officer at ATAI Life Sciences NV. Mr. Weaver is also on the board of Atossa Therapeutics, Inc. and NOXXON Pharma NV.

In his past career he held the position of Chief Financial Officer at Poniard Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President of Celsion Corp., Global Chief Financial Officer & Executive VP at Oryzon Genomics SA, Chief Financial & Accounting Officer at Eloxx Pharmaceuticals, Inc. and Chief Financial Officer for Sevion Therapeutics, Inc. (a subsidiary of Eloxx Pharmaceuticals, Inc.), Chief Financial Officer, Secretary & VP at MDRNA, Inc., Chief Financial Officer & Senior Vice President at Sirna Therapeutics, Inc., CFO, Secretary, Treasurer & Senior Vice President at Fibrocell Science, Inc., Chief Financial Officer for ILEX Oncology, Inc., Chief Financial Officer at Liminal BioSciences, Inc., Chief Financial Officer of Prism Technologies, Inc., Chief Financial Officer for Verity Solutions Group, Inc. and Chief Financial Officer for Oncology, Inc.

He received an MBA from Boston College and an undergraduate degree from Trinity University.


Current positions of Gregory L. Weaver 
NameTitle Since
Atai Life Sciences N.V.
(Biotechnology & Medical Research)
Chief Financial Officer 2020
Atossa Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2013
NOXXON Pharma N.V.
(Biotechnology & Medical Research)
Member-Supervisory Board 2021


Holdings of Gregory L. Weaver 
NameEquities%Valuation
Atai Life Sciences N.V. (ATAI)
(Biotechnology & Medical Research)
4,6660.0030%76,429 USD


Gregory L. Weaver: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Gregory L. Weaver : Connections